Invesco’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $541K | Sell |
150,202
-22,954
| -13% | -$82.6K | ﹤0.01% | 3126 |
|
|
2025
Q1 | $518K | Sell |
173,156
-23,546
| -12% | -$70.4K | ﹤0.01% | 3127 |
|
|
2024
Q4 | $659K | Buy |
196,702
+2,173
| +1% | +$7.28K | ﹤0.01% | 3101 |
|
|
2024
Q3 | $652K | Sell |
194,529
-508
| -0.3% | -$1.7K | ﹤0.01% | 3103 |
|
|
2024
Q2 | $646K | Sell |
195,037
-1,227
| -0.6% | -$4.06K | ﹤0.01% | 3153 |
|
|
2024
Q1 | $793K | Sell |
196,264
-25,301
| -11% | -$102K | ﹤0.01% | 3095 |
|
|
2023
Q4 | $676K | Buy |
221,565
+9,454
| +4% | +$28.8K | ﹤0.01% | 3060 |
|
|
2023
Q3 | $636K | Buy |
212,111
+1,581
| +0.8% | +$4.74K | ﹤0.01% | 3076 |
|
|
2023
Q2 | $787K | Sell |
210,530
-6,244
| -3% | -$23.4K | ﹤0.01% | 2994 |
|
|
2023
Q1 | $726K | Buy |
216,774
+68,845
| +47% | +$231K | ﹤0.01% | 3052 |
|
|
2022
Q4 | $712K | Buy |
147,929
+31,289
| +27% | +$151K | ﹤0.01% | 3086 |
|
|
2022
Q3 | $664K | Sell |
116,640
-4,492
| -4% | -$25.6K | ﹤0.01% | 3076 |
|
|
2022
Q2 | $860K | Buy |
121,132
+16,114
| +15% | +$114K | ﹤0.01% | 3037 |
|
|
2022
Q1 | $758K | Buy |
105,018
+71,725
| +215% | +$518K | ﹤0.01% | 3175 |
|
|
2021
Q4 | $297K | Sell |
33,293
-284,286
| -90% | -$2.54M | ﹤0.01% | 3582 |
|
|
2021
Q3 | $11.1M | Buy |
317,579
+295,781
| +1,357% | +$10.4M | ﹤0.01% | 1938 |
|
|
2021
Q2 | $468K | Buy |
21,798
+13,256
| +155% | +$285K | ﹤0.01% | 3420 |
|
|
2021
Q1 | $527K | Buy |
+8,542
| New | +$527K | ﹤0.01% | 3300 |
|